2LW-32842-81869
2 vaccinations
2 coded responses
4 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 117 / NY
- Registered
- 2021-04-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Dose 1 — Moderna
-
2021-02-18
Dose 2 — Moderna
-
2021-04-24
Registered in v-safe
-
2021-04-24
Survey response — 3 months, dose 1MedDRA: Urinary tract infection, Vaginal disorder, Vaginal infection, Vulvovaginal mycotic infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vaginal issues (UTI/yeast infections)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
- 2021-08-19
-
2022-02-22
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-23
-
2022-02-23
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Moderna | |
| 2 | 2021-02-18 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-24 | Successful | Participant prefers to complete VAERS report online |
| 2022-02-22 | Successful 2022-02-23 |
Participant prefers to complete VAERS report online |
Free text
Release 7 — 3 months, dose 1
Symptoms: Vaginal issues (UTI/yeast infections)
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SD | Vaginal disorder | · | · | ✓ |
| SD | Vaginal infection | ✓ | ✓ | ○ |
| SD | Vulvovaginal mycotic infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release